STOCK TITAN

Dolby Laboratories (DLB) DEF 14A Filings

DLB NYSE

Here are the DEF 14A proxy statements from Dolby Laboratories, Inc. (DLB) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow DLB and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DLB filings page.

Rhea-AI Summary

Dolby Laboratories, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on February 3, 2026, including the election of eight directors, an advisory vote on named executive officer compensation, and ratification of KPMG LLP as independent auditor.

For fiscal 2025, Dolby reports total revenue of $1.35 billion versus $1.27 billion in 2024, a 6.3% increase, while net income was $255.0 million versus $261.8 million, a 2.6% decline. Non‑GAAP net income rose to $413.5 million and non‑GAAP diluted EPS to $4.24. Diluted EPS was $2.62, the year‑end share price was $72.39, and in November 2025 the quarterly dividend was raised 9%, from $0.33 to $0.36 per share.

The proxy describes a pay‑for‑performance program that kept named executive officer base salaries flat for 2025 and ties annual bonuses to revenue and non‑GAAP operating income. For fiscal 2025, non‑GAAP operating income of $447.5 million and revenue of $1,349.1 million produced payouts at 94% of target bonuses. Long‑term incentives are primarily equity awards, including performance stock units that vested at 70.37% of target for the 2022–2025 cycle based on relative total stockholder return.